@Article{Chmielewska2008,
journal="Klinika Oczna / Acta Ophthalmologica Polonica",
issn="0023-2157",
volume="110",
number="3",
year="2008",
title="Rola nabłonka barwnikowego siatkówki 
w patogenezie cukrzycowego obrzęku plamki 
i jego leczeniu",
abstract="Pigment epithelium-derived factor (PEDF) has recently been shown to be the most potent inhibitor of angiogenesis in the mammalian eye, suggesting that loss of PEDF is involved in the pathogenesis of proliferative diabetic retinopathy. However, a protective role for PEDF in pericyte loss requires elucidation. Present studies suggest that PEDF proteins could protect against  advanced glycation end product (AGE), which induce injury in retinal pericytes. Substitution of PEDF proteins may be a promising strategy in the treatment of patients with early diabetic retinopathy. Therefore, injury of RPE is the basic condition, not  only of the progress of neovascularization, but initiation of early diabetic microangiopathy and macular edema as well. Recently  new intravitreal drugs being used in the treatment of eye diseases with increased level of VEGF. Intravitreally administered a human, monoclonal anti-VEGF agent acts only as symptomatic treatment. It does not eliminate hypoxia and requires repeated   administration. It is worth emphasizing, that VEGF functions are not limited to active angiogenesis, but also seems to require  the maintenance and differentiation of mature blood vessels, such as the choriocapillaris. Therefore, delivery of these anti-VEGF  treatments needs to be specific to sites of neovascularization or limited to a short duration, to prevent disruption of the normal  vasculature. The effective method, which preserves RPE, improves oxygenation and release traction on the macula, leading to  decreased permeability with subsequent resolution in DME, is pars plana vitrectomy with ILM peeling. There are several investigations that support the theoretical value of vitrectomy for the treatment of DME. Intraoperative administration of anti-VEGF  agent and corticosteroids may additionally improve results of operative treatment.",
author="Chmielewska, Katarzyna
and Robaszkiewicz, Jacek
and Kosatka, Mariusz",
pages="318--320",
url="https://www.termedia.pl/Role-of-the-retinal-pigment-epithelium-RPE-r-nin-the-pathogenesis-and-treatment-r-nof-diabetic-macular-edema-DME-,124,48758,1,1.html"
}